1. Zhao. W.#,Xu. Q., Yang J., Xie. XH., Li CM., Zhang. WH., Chen EH., Guo YF., Gao. MY., Shi. J., Zhang HB., Yao. H., Li. MX., Yan L., Fang. F., Wu. WM.*, Liu. XJ.* Murine double minute 2 aggravates adipose tissue dysfunction through ubiquitin-mediated six-transmembrane epithelial antigen of prostate 4 degradation. iSience 2022,10.1016/j.isci.2022.104544.(IF=6.1074)
2. Hua. S.#, Gao. J., Wang Z., Yeerkenbieke. P., Li. J., Wang J., He. G., Jiang. J., Lu. Y., Yu. Q., Han. X., Liao. Q., Wu. W*.Automatic bleeding detection in laparoscopic surgery based on a faster region-based convolutional neural network. Annals of Translational Medicine 2022,10.21 037/atm-22-1914. (IF=3.616)
3. Ling C#., Hong X., Xu M., Wang Y., Ma X., Cui Y., Jiang R., Cao D., Wu H., Tong A., Zhao Y., Wu W*. Convergence between germline and somatic mutations in pancreatic neuroendocrine tumors. European journal of endocrinology 2022,10.1530/EJE-21-0893. (IF=6.558)
4. Wang, X#., Chen, H., Jiang, R., Hong, X., Peng, J., Chen, W., Jiang, J., Li, J., Huang, D., Dai, H., Wang, W., Lu, J., Zhao, Y.8, Wu, W*. Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenocarcinoma. Cancer Letters 2021,508:1-12. (IF=9.756)
5. Wu W.#, Chen J., Bai C., Chi Y., Du Y., Feng S., Huo L., Jiang Y., Li J., Lou W., Luo J., Shao C., Shen L., Wang F., Wang L., Wang O., Wang Y., Wu H., Xing X., Xu J., Xue H., Xue L., Yang Y., Yu X., Yuan C., Zhao H., Zhu X., Zhao Y*. The Chinese guidelines for the diagnosis and treatment of pancreatic neuroendocrine neoplasms (2020). Journal of Pancreatology 2021,10.1097/JP9.0000000000000064.
6. Li Y.#, He Y., Peng J., Su Z., Li Z., Zhang B., Ma J., Zhuo M., Zou D., Liu X., Liu X., Wang W., Huang D., Xu M., Wang J., Deng H., Xue J., Xie W., Lan X., Chen M., Zhao Y., Wu W.*, David C.J*. Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer. Nature Cancer. 2021,10.1038/s43018-020-00134-z. (IF=23)
7. Hong, X#., Qiao, S., Li, F., Wang, W., Jiang, R., Wu, H., Chen, H., Liu, L., Peng, J., Wang, J., Jia, C., Liang, X., Dai, H., Jiang, J., Zhang, T., Liao, Q., Dai, M., Cong, L., Han, X., Guo, D., Liang, Z., Li, D., Zheng, Z., Ye, C., Li, S., Zhao, Y., Wu, K., Wu, W*. Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: Leading to a new classification system. Gut 2020, 69(5):877-887. (IF=31.84, R)
8. Peng, J#., Liu, L., Huang, D., Chen, H., Dai, M., Guo, J., Zhang, T., Liao, Q., Jiang, J., Wang, W., Guo, D., Cao, D., Xuan, Z., Li, D., Zhao, Y., Wu, W*. Impact of ischemia on sample quality of human pancreatic tissues. Pancreatology 2020, 20(2):265-277. (IF=3.977)
9. Dai, H#., Chen, H., Hong, X., Han, X., Xu, Q., Pang, H., Yuan, J., Wang, X., Xu, P., Jiang, J., Jiang, R., Zhuang, Z., Zhao, Y., Wu, W*. Early detection of cognitive impairment in patients with insulinoma. Endocrine 2019, 65(3):524-530. (IF=3.925)
10. Peng, J#., Sun, B.-F., Chen, C.-Y., Zhou, J.-Y., Chen, Y.-S., Chen, H., Liu, L., Huang, D., Jiang, J., Cui, G.-S., Yang, Y., Wang, W., Guo, D., Dai, M., Guo, J., Zhang, T., Liao, Q., Liu, Y., Zhao, Y.-L., Han, D.-L., Zhao, Y., Yang, Y.-G., Wu, W*. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Research 2019, 29(9):(725-738), 10.1038/s41422-019-0195-y). Cell Research 29(9): 777. (IF=46.378, C100, ESI)